The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice (Q27318414)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice	scientific article

Statements

scholarly article

0 references

The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Stefano Fiorucci

8

0 references

Daniela Francisci

4

0 references

author name string

Andrea Mencarelli

1

0 references

Sabrina Cipriani

2

0 references

Barbara Renga

3

0 references

Giuseppe Palladino

5

0 references

Eleonora Distrutti

6

0 references

Franco Baldelli

7

0 references

language of work or name

0 references

publication date

2010

0 references

0 references

5

0 references

10

0 references

e13238

0 references

copyright license

Creative Commons Attribution 4.0 International

8 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Identification of a nuclear receptor for bile acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

21 March 2017

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

21 March 2017

Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

21 March 2017

Inflammation in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

7 April 2017

Bile acid-activated receptors in the treatment of dyslipidemia and related disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Update on HAART in HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

ATP-binding cassette transporter AI and its role in HDL formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Expression and activation of the farnesoid X receptor in the vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Innate and acquired immunity in atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Scavenger receptors, oxidized LDL, and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Class A scavenger receptors, macrophages, and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Hyperlipidemia and inhibitors of HIV protease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

CD36 and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

28 September 2017

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

31 May 2018

HIV-protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

31 May 2018

Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951893

31 May 2018

Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Antiatherosclerotic effect of farnesoid X receptor

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

HIV protease inhibitors stimulate hepatic triglyceride synthesis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Redundant pathways for negative feedback regulation of bile acid production

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Cardiovascular Risks of Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013238

21 January 2018

Coronary heart disease in HIV-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pregnane X receptor is a target of farnesoid X receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20949026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0013238

0 references

2010PLoSO...513238M

0 references

release_wuvh4nxtp5bw3pa6wpbkmz6u5u

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27318414&oldid=1869951455"